Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Halda Therapeutics

Request full access

Precision oncology therapies targeting cancer via RIPTAC™ chimera

New Haven, United StatesFounded 2018Biotech & Life Sciences

About Halda Therapeutics

Halda is a biotechnology company focused on developing a new class of precision medicines known as RIPTAC therapeutics to combat cancer. These innovative drugs work by holding two proteins together: one that is tumor-specific and another that performs an essential function, resulting in the selective killing of cancer cells. Halda operates in the biotechnology and pharmaceutical market, primarily serving patients and healthcare providers in the oncology sector. The company's business model revolves around the research, development, and commercialization of these novel therapeutics. Revenue is generated through the sale of these drugs, as well as potential partnerships and licensing agreements with larger pharmaceutical companies. Halda's leadership team, including CFO Scott Phillips, brings extensive experience in finance and biotech, ensuring robust financial management and strategic growth.

Source: Dealroom company data

Halda Therapeutics in the New Haven ecosystem

Live from Dealroom

The Halda Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A10 investors entered at this stage

  • Frazier Life Sciences
  • Access Industries
  • Canaan
  • Connecticut Innovations
  • Taiho Pharma
  • Vida Ventures
  • RA Capital Management
  • Elm Street Ventures
  • Boxer Capital
  • Deep Track Capital

Series B and later11 investors entered at this stage

  • Taiho Pharma
  • RA Capital Management
  • Deep Track Capital
  • Frazier Life Sciences
  • Access Industries
  • Yale University
  • Elm Street Ventures
  • Connecticut Innovations
  • Vida Ventures
  • Canaan
  • Boxer Capital
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$246k

14 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Halda Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.